Evidence map›Paper›PMID 38306329›Full record

ArticlePloS one2024

Machine learning-based identification of contrast-enhancement phase of computed tomography scans.

Siddharth Guha, Abdalla Ibrahim, Qian Wu, Pengfei Geng, Yen Chou, Hao Yang, Jingchen Ma, Lin Lu, Delin Wang, Lawrence H Schwartz and 2 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Siddharth GuhaDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.ORCID 0009-0002-2326-4482
Abdalla IbrahimDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.
Qian WuDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.
Pengfei GengDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.
Yen ChouDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.ORCID 0000-0003-2388-194X
Hao YangDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.
Jingchen MaDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.
Lin LuDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.
Delin WangSun Yat-Sen University Cancer Center, Guangzhou, China.
Lawrence H SchwartzDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.
Chuan-Miao XieSun Yat-Sen University Cancer Center, Guangzhou, China.
Binsheng ZhaoDepartment of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.ORCID 0000-0003-1835-7916

Funding

Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung CancerU01CA225431 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SCHWARTZ, LAWRENCE H, ZHAO, BINSHENG · 2018 to 2022
$3.1M
NCI NIH HHS U01 CA225431
6 · The paper itself

Abstract

Contrast-enhanced computed tomography scans (CECT) are routinely used in the evaluation of different clinical scenarios, including the detection and characterization of hepatocellular carcinoma (HCC). Quantitative medical image analysis has been an exponentially growing scientific field. A number of studies reported on the effects of variations in the contrast enhancement phase on the reproducibility of quantitative imaging features extracted from CT scans. The identification and labeling of phase enhancement is a time-consuming task, with a current need for an accurate automated labeling algorithm to identify the enhancement phase of CT scans. In this study, we investigated the ability of machine learning algorithms to label the phases in a dataset of 59 HCC patients scanned with a dynamic contrast-enhanced CT protocol. The ground truth labels were provided by expert radiologists. Regions of interest were defined within the aorta, the portal vein, and the liver. Mean density values were extracted from those regions of interest and used for machine learning modeling. Models were evaluated using accuracy, the area under the curve (AUC), and Matthew's correlation coefficient (MCC). We tested the algorithms on an external dataset (76 patients). Our results indicate that several supervised learning algorithms (logistic regression, random forest, etc.) performed similarly, and our developed algorithms can accurately classify the phase of contrast enhancement.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAlgorithmsHumansMachine LearningReproducibility of ResultsRetrospective StudiesTomography, X-Ray Computed

Identifiers

PMID38306329
PMCPMC10836663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.